annotation	title	geo_accession	status	submission_date	last_update_date	type	channel_count	source_name_ch1	organism_ch1	characteristics_ch1	characteristics_ch1.1	characteristics_ch1.2	treatment_protocol_ch1	growth_protocol_ch1	molecule_ch1	extract_protocol_ch1	extract_protocol_ch1.1	extract_protocol_ch1.2	taxid_ch1	description	description.1	description.2	data_processing	data_processing.1	data_processing.2	data_processing.3	data_processing.4	data_processing.5	platform_id	contact_name	contact_institute	contact_address	contact_city	contact_state	contact_zip/postal_code	contact_country	data_row_count	instrument_model	library_selection	library_source	library_strategy	relation	relation.1	supplementary_file_1	cell line:ch1	infection:ch1	sgrna pool:ch1
GPL29759	Expanded Interactome Mock 1	GSM5102434	Public on Feb 24 2021	Feb 23 2021	Feb 24 2021	SRA	1	VeroE6 cells	Chlorocebus sabaeus	sgrna pool: SARS-CoV-2 RNA interactome	cell line: VeroE6-Cas9 v2	infection: none	Each culture was treated with the virus indicated in the Characteristics "infection" field above to select for resistance or sensitization sgRNAs.	VeroE6 cells expressing Cas9v2 and their respective sgRNA pool were maintained in T150 flasks in 5% FBS.	genomic DNA	gDNA was extracted from each sample using standard commercial kits (Zymo).	Lentivirally-integrated sgRNAs were PCR amplified from each gDNA sample and sequencing adapters and indices were added.	Targeted (amplicon) sequencing	60711	CRISPR sgRNAs from gDNA	exp_counts_table.tsv	exp_mock_1	Adapter trimming was performed using fastp	Reads were mapped to the relevant sgRNA library using hisat2 and a custom genome (fasta) file for each sgRNA library.	BAM files were converted to counts tables using R package `Rsamtools`	Counts were depth normalized and then z-scored using negative controls	Genome_build: Designed sgRNA sequences were used to create a custom fasta file used for alignments.	Supplementary_files_format_and_content: Counts table for each sgRNA	GPL29759	Julia,,Belk	Stanford University	450 Serra Mall	Stanford	California	94305	USA	0	NextSeq 550	other	genomic	OTHER	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN18037893	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10156564	NONE	VeroE6-Cas9 v2	none	SARS-CoV-2 RNA interactome
GPL29759	Expanded Interactome Mock 2	GSM5102435	Public on Feb 24 2021	Feb 23 2021	Feb 24 2021	SRA	1	VeroE6 cells	Chlorocebus sabaeus	sgrna pool: SARS-CoV-2 RNA interactome	cell line: VeroE6-Cas9 v2	infection: none	Each culture was treated with the virus indicated in the Characteristics "infection" field above to select for resistance or sensitization sgRNAs.	VeroE6 cells expressing Cas9v2 and their respective sgRNA pool were maintained in T150 flasks in 5% FBS.	genomic DNA	gDNA was extracted from each sample using standard commercial kits (Zymo).	Lentivirally-integrated sgRNAs were PCR amplified from each gDNA sample and sequencing adapters and indices were added.	Targeted (amplicon) sequencing	60711	CRISPR sgRNAs from gDNA	exp_counts_table.tsv	exp_mock_2	Adapter trimming was performed using fastp	Reads were mapped to the relevant sgRNA library using hisat2 and a custom genome (fasta) file for each sgRNA library.	BAM files were converted to counts tables using R package `Rsamtools`	Counts were depth normalized and then z-scored using negative controls	Genome_build: Designed sgRNA sequences were used to create a custom fasta file used for alignments.	Supplementary_files_format_and_content: Counts table for each sgRNA	GPL29759	Julia,,Belk	Stanford University	450 Serra Mall	Stanford	California	94305	USA	0	NextSeq 550	other	genomic	OTHER	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN18037892	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10156565	NONE	VeroE6-Cas9 v2	none	SARS-CoV-2 RNA interactome
GPL29759	Expanded Interactome rcVSV 1	GSM5102436	Public on Feb 24 2021	Feb 23 2021	Feb 24 2021	SRA	1	VeroE6 cells	Chlorocebus sabaeus	sgrna pool: SARS-CoV-2 RNA interactome	cell line: VeroE6-Cas9 v2	infection: rcVSV-SARS-2-S	Each culture was treated with the virus indicated in the Characteristics "infection" field above to select for resistance or sensitization sgRNAs.	VeroE6 cells expressing Cas9v2 and their respective sgRNA pool were maintained in T150 flasks in 5% FBS.	genomic DNA	gDNA was extracted from each sample using standard commercial kits (Zymo).	Lentivirally-integrated sgRNAs were PCR amplified from each gDNA sample and sequencing adapters and indices were added.	Targeted (amplicon) sequencing	60711	CRISPR sgRNAs from gDNA	exp_counts_table.tsv	exp_rcVSV_1	Adapter trimming was performed using fastp	Reads were mapped to the relevant sgRNA library using hisat2 and a custom genome (fasta) file for each sgRNA library.	BAM files were converted to counts tables using R package `Rsamtools`	Counts were depth normalized and then z-scored using negative controls	Genome_build: Designed sgRNA sequences were used to create a custom fasta file used for alignments.	Supplementary_files_format_and_content: Counts table for each sgRNA	GPL29759	Julia,,Belk	Stanford University	450 Serra Mall	Stanford	California	94305	USA	0	NextSeq 550	other	genomic	OTHER	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN18037891	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10156566	NONE	VeroE6-Cas9 v2	rcVSV-SARS-2-S	SARS-CoV-2 RNA interactome
GPL29759	Expanded Interactome rcVSV 2	GSM5102437	Public on Feb 24 2021	Feb 23 2021	Feb 24 2021	SRA	1	VeroE6 cells	Chlorocebus sabaeus	sgrna pool: SARS-CoV-2 RNA interactome	cell line: VeroE6-Cas9 v2	infection: rcVSV-SARS-2-S	Each culture was treated with the virus indicated in the Characteristics "infection" field above to select for resistance or sensitization sgRNAs.	VeroE6 cells expressing Cas9v2 and their respective sgRNA pool were maintained in T150 flasks in 5% FBS.	genomic DNA	gDNA was extracted from each sample using standard commercial kits (Zymo).	Lentivirally-integrated sgRNAs were PCR amplified from each gDNA sample and sequencing adapters and indices were added.	Targeted (amplicon) sequencing	60711	CRISPR sgRNAs from gDNA	exp_counts_table.tsv	exp_rcVSV_2	Adapter trimming was performed using fastp	Reads were mapped to the relevant sgRNA library using hisat2 and a custom genome (fasta) file for each sgRNA library.	BAM files were converted to counts tables using R package `Rsamtools`	Counts were depth normalized and then z-scored using negative controls	Genome_build: Designed sgRNA sequences were used to create a custom fasta file used for alignments.	Supplementary_files_format_and_content: Counts table for each sgRNA	GPL29759	Julia,,Belk	Stanford University	450 Serra Mall	Stanford	California	94305	USA	0	NextSeq 550	other	genomic	OTHER	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN18037890	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10156567	NONE	VeroE6-Cas9 v2	rcVSV-SARS-2-S	SARS-CoV-2 RNA interactome
GPL29759	Expanded Interactome HKU5 1	GSM5102438	Public on Feb 24 2021	Feb 23 2021	Feb 24 2021	SRA	1	VeroE6 cells	Chlorocebus sabaeus	sgrna pool: SARS-CoV-2 RNA interactome	cell line: VeroE6-Cas9 v2	infection: HKU5-SARS1	Each culture was treated with the virus indicated in the Characteristics "infection" field above to select for resistance or sensitization sgRNAs.	VeroE6 cells expressing Cas9v2 and their respective sgRNA pool were maintained in T150 flasks in 5% FBS.	genomic DNA	gDNA was extracted from each sample using standard commercial kits (Zymo).	Lentivirally-integrated sgRNAs were PCR amplified from each gDNA sample and sequencing adapters and indices were added.	Targeted (amplicon) sequencing	60711	CRISPR sgRNAs from gDNA	exp_counts_table.tsv	exp_hku5_1	Adapter trimming was performed using fastp	Reads were mapped to the relevant sgRNA library using hisat2 and a custom genome (fasta) file for each sgRNA library.	BAM files were converted to counts tables using R package `Rsamtools`	Counts were depth normalized and then z-scored using negative controls	Genome_build: Designed sgRNA sequences were used to create a custom fasta file used for alignments.	Supplementary_files_format_and_content: Counts table for each sgRNA	GPL29759	Julia,,Belk	Stanford University	450 Serra Mall	Stanford	California	94305	USA	0	NextSeq 550	other	genomic	OTHER	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN18037889	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10156568	NONE	VeroE6-Cas9 v2	HKU5-SARS1	SARS-CoV-2 RNA interactome
GPL29759	Expanded Interactome HKU5 2	GSM5102439	Public on Feb 24 2021	Feb 23 2021	Feb 24 2021	SRA	1	VeroE6 cells	Chlorocebus sabaeus	sgrna pool: SARS-CoV-2 RNA interactome	cell line: VeroE6-Cas9 v2	infection: HKU5-SARS1	Each culture was treated with the virus indicated in the Characteristics "infection" field above to select for resistance or sensitization sgRNAs.	VeroE6 cells expressing Cas9v2 and their respective sgRNA pool were maintained in T150 flasks in 5% FBS.	genomic DNA	gDNA was extracted from each sample using standard commercial kits (Zymo).	Lentivirally-integrated sgRNAs were PCR amplified from each gDNA sample and sequencing adapters and indices were added.	Targeted (amplicon) sequencing	60711	CRISPR sgRNAs from gDNA	exp_counts_table.tsv	exp_hku5_2	Adapter trimming was performed using fastp	Reads were mapped to the relevant sgRNA library using hisat2 and a custom genome (fasta) file for each sgRNA library.	BAM files were converted to counts tables using R package `Rsamtools`	Counts were depth normalized and then z-scored using negative controls	Genome_build: Designed sgRNA sequences were used to create a custom fasta file used for alignments.	Supplementary_files_format_and_content: Counts table for each sgRNA	GPL29759	Julia,,Belk	Stanford University	450 Serra Mall	Stanford	California	94305	USA	0	NextSeq 550	other	genomic	OTHER	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN18037888	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10156569	NONE	VeroE6-Cas9 v2	HKU5-SARS1	SARS-CoV-2 RNA interactome
GPL29759	Expanded Interactome SARS2 1	GSM5102440	Public on Feb 24 2021	Feb 23 2021	Feb 24 2021	SRA	1	VeroE6 cells	Chlorocebus sabaeus	sgrna pool: SARS-CoV-2 RNA interactome	cell line: VeroE6-Cas9 v2	infection: SARS-CoV-2	Each culture was treated with the virus indicated in the Characteristics "infection" field above to select for resistance or sensitization sgRNAs.	VeroE6 cells expressing Cas9v2 and their respective sgRNA pool were maintained in T150 flasks in 5% FBS.	genomic DNA	gDNA was extracted from each sample using standard commercial kits (Zymo).	Lentivirally-integrated sgRNAs were PCR amplified from each gDNA sample and sequencing adapters and indices were added.	Targeted (amplicon) sequencing	60711	CRISPR sgRNAs from gDNA	exp_counts_table.tsv	exp_sars2_1	Adapter trimming was performed using fastp	Reads were mapped to the relevant sgRNA library using hisat2 and a custom genome (fasta) file for each sgRNA library.	BAM files were converted to counts tables using R package `Rsamtools`	Counts were depth normalized and then z-scored using negative controls	Genome_build: Designed sgRNA sequences were used to create a custom fasta file used for alignments.	Supplementary_files_format_and_content: Counts table for each sgRNA	GPL29759	Julia,,Belk	Stanford University	450 Serra Mall	Stanford	California	94305	USA	0	NextSeq 550	other	genomic	OTHER	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN18037887	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10156570	NONE	VeroE6-Cas9 v2	SARS-CoV-2	SARS-CoV-2 RNA interactome
GPL29759	Expanded Interactome SARS2 2	GSM5102441	Public on Feb 24 2021	Feb 23 2021	Feb 24 2021	SRA	1	VeroE6 cells	Chlorocebus sabaeus	sgrna pool: SARS-CoV-2 RNA interactome	cell line: VeroE6-Cas9 v2	infection: SARS-CoV-2	Each culture was treated with the virus indicated in the Characteristics "infection" field above to select for resistance or sensitization sgRNAs.	VeroE6 cells expressing Cas9v2 and their respective sgRNA pool were maintained in T150 flasks in 5% FBS.	genomic DNA	gDNA was extracted from each sample using standard commercial kits (Zymo).	Lentivirally-integrated sgRNAs were PCR amplified from each gDNA sample and sequencing adapters and indices were added.	Targeted (amplicon) sequencing	60711	CRISPR sgRNAs from gDNA	exp_counts_table.tsv	exp_sars2_2	Adapter trimming was performed using fastp	Reads were mapped to the relevant sgRNA library using hisat2 and a custom genome (fasta) file for each sgRNA library.	BAM files were converted to counts tables using R package `Rsamtools`	Counts were depth normalized and then z-scored using negative controls	Genome_build: Designed sgRNA sequences were used to create a custom fasta file used for alignments.	Supplementary_files_format_and_content: Counts table for each sgRNA	GPL29759	Julia,,Belk	Stanford University	450 Serra Mall	Stanford	California	94305	USA	0	NextSeq 550	other	genomic	OTHER	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN18037886	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10156571	NONE	VeroE6-Cas9 v2	SARS-CoV-2	SARS-CoV-2 RNA interactome
GPL29759	Expanded Interactome MERS 1	GSM5102442	Public on Feb 24 2021	Feb 23 2021	Feb 24 2021	SRA	1	VeroE6 cells	Chlorocebus sabaeus	sgrna pool: SARS-CoV-2 RNA interactome	cell line: VeroE6-Cas9 v2	infection: MERS WT	Each culture was treated with the virus indicated in the Characteristics "infection" field above to select for resistance or sensitization sgRNAs.	VeroE6 cells expressing Cas9v2 and their respective sgRNA pool were maintained in T150 flasks in 5% FBS.	genomic DNA	gDNA was extracted from each sample using standard commercial kits (Zymo).	Lentivirally-integrated sgRNAs were PCR amplified from each gDNA sample and sequencing adapters and indices were added.	Targeted (amplicon) sequencing	60711	CRISPR sgRNAs from gDNA	exp_counts_table.tsv	exp_mers_1	Adapter trimming was performed using fastp	Reads were mapped to the relevant sgRNA library using hisat2 and a custom genome (fasta) file for each sgRNA library.	BAM files were converted to counts tables using R package `Rsamtools`	Counts were depth normalized and then z-scored using negative controls	Genome_build: Designed sgRNA sequences were used to create a custom fasta file used for alignments.	Supplementary_files_format_and_content: Counts table for each sgRNA	GPL29759	Julia,,Belk	Stanford University	450 Serra Mall	Stanford	California	94305	USA	0	NextSeq 550	other	genomic	OTHER	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN18037880	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10156572	NONE	VeroE6-Cas9 v2	MERS WT	SARS-CoV-2 RNA interactome
GPL29759	Expanded Interactome MERS 2	GSM5102443	Public on Feb 24 2021	Feb 23 2021	Feb 24 2021	SRA	1	VeroE6 cells	Chlorocebus sabaeus	sgrna pool: SARS-CoV-2 RNA interactome	cell line: VeroE6-Cas9 v2	infection: MERS WT	Each culture was treated with the virus indicated in the Characteristics "infection" field above to select for resistance or sensitization sgRNAs.	VeroE6 cells expressing Cas9v2 and their respective sgRNA pool were maintained in T150 flasks in 5% FBS.	genomic DNA	gDNA was extracted from each sample using standard commercial kits (Zymo).	Lentivirally-integrated sgRNAs were PCR amplified from each gDNA sample and sequencing adapters and indices were added.	Targeted (amplicon) sequencing	60711	CRISPR sgRNAs from gDNA	exp_counts_table.tsv	exp_mers_2	Adapter trimming was performed using fastp	Reads were mapped to the relevant sgRNA library using hisat2 and a custom genome (fasta) file for each sgRNA library.	BAM files were converted to counts tables using R package `Rsamtools`	Counts were depth normalized and then z-scored using negative controls	Genome_build: Designed sgRNA sequences were used to create a custom fasta file used for alignments.	Supplementary_files_format_and_content: Counts table for each sgRNA	GPL29759	Julia,,Belk	Stanford University	450 Serra Mall	Stanford	California	94305	USA	0	NextSeq 550	other	genomic	OTHER	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN18037879	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10156573	NONE	VeroE6-Cas9 v2	MERS WT	SARS-CoV-2 RNA interactome
GPL29759	Expanded Interactome T1015N 1	GSM5102444	Public on Feb 24 2021	Feb 23 2021	Feb 24 2021	SRA	1	VeroE6 cells	Chlorocebus sabaeus	sgrna pool: SARS-CoV-2 RNA interactome	cell line: VeroE6-Cas9 v2	infection: MERS T1015N	Each culture was treated with the virus indicated in the Characteristics "infection" field above to select for resistance or sensitization sgRNAs.	VeroE6 cells expressing Cas9v2 and their respective sgRNA pool were maintained in T150 flasks in 5% FBS.	genomic DNA	gDNA was extracted from each sample using standard commercial kits (Zymo).	Lentivirally-integrated sgRNAs were PCR amplified from each gDNA sample and sequencing adapters and indices were added.	Targeted (amplicon) sequencing	60711	CRISPR sgRNAs from gDNA	exp_counts_table.tsv	exp_t1015n_1	Adapter trimming was performed using fastp	Reads were mapped to the relevant sgRNA library using hisat2 and a custom genome (fasta) file for each sgRNA library.	BAM files were converted to counts tables using R package `Rsamtools`	Counts were depth normalized and then z-scored using negative controls	Genome_build: Designed sgRNA sequences were used to create a custom fasta file used for alignments.	Supplementary_files_format_and_content: Counts table for each sgRNA	GPL29759	Julia,,Belk	Stanford University	450 Serra Mall	Stanford	California	94305	USA	0	NextSeq 550	other	genomic	OTHER	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN18037907	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10156574	NONE	VeroE6-Cas9 v2	MERS T1015N	SARS-CoV-2 RNA interactome
GPL29759	Expanded Interactome T1015N 2	GSM5102445	Public on Feb 24 2021	Feb 23 2021	Feb 24 2021	SRA	1	VeroE6 cells	Chlorocebus sabaeus	sgrna pool: SARS-CoV-2 RNA interactome	cell line: VeroE6-Cas9 v2	infection: MERS T1015N	Each culture was treated with the virus indicated in the Characteristics "infection" field above to select for resistance or sensitization sgRNAs.	VeroE6 cells expressing Cas9v2 and their respective sgRNA pool were maintained in T150 flasks in 5% FBS.	genomic DNA	gDNA was extracted from each sample using standard commercial kits (Zymo).	Lentivirally-integrated sgRNAs were PCR amplified from each gDNA sample and sequencing adapters and indices were added.	Targeted (amplicon) sequencing	60711	CRISPR sgRNAs from gDNA	exp_counts_table.tsv	exp_t1015n_2	Adapter trimming was performed using fastp	Reads were mapped to the relevant sgRNA library using hisat2 and a custom genome (fasta) file for each sgRNA library.	BAM files were converted to counts tables using R package `Rsamtools`	Counts were depth normalized and then z-scored using negative controls	Genome_build: Designed sgRNA sequences were used to create a custom fasta file used for alignments.	Supplementary_files_format_and_content: Counts table for each sgRNA	GPL29759	Julia,,Belk	Stanford University	450 Serra Mall	Stanford	California	94305	USA	0	NextSeq 550	other	genomic	OTHER	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN18037885	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10156575	NONE	VeroE6-Cas9 v2	MERS T1015N	SARS-CoV-2 RNA interactome
GPL29759	Expanded Interactome EMCV 1	GSM5102446	Public on Feb 24 2021	Feb 23 2021	Feb 24 2021	SRA	1	VeroE6 cells	Chlorocebus sabaeus	sgrna pool: SARS-CoV-2 RNA interactome	cell line: VeroE6-Cas9 v2	infection: EMCV	Each culture was treated with the virus indicated in the Characteristics "infection" field above to select for resistance or sensitization sgRNAs.	VeroE6 cells expressing Cas9v2 and their respective sgRNA pool were maintained in T150 flasks in 5% FBS.	genomic DNA	gDNA was extracted from each sample using standard commercial kits (Zymo).	Lentivirally-integrated sgRNAs were PCR amplified from each gDNA sample and sequencing adapters and indices were added.	Targeted (amplicon) sequencing	60711	CRISPR sgRNAs from gDNA	exp_counts_table.tsv	exp_emcv_1	Adapter trimming was performed using fastp	Reads were mapped to the relevant sgRNA library using hisat2 and a custom genome (fasta) file for each sgRNA library.	BAM files were converted to counts tables using R package `Rsamtools`	Counts were depth normalized and then z-scored using negative controls	Genome_build: Designed sgRNA sequences were used to create a custom fasta file used for alignments.	Supplementary_files_format_and_content: Counts table for each sgRNA	GPL29759	Julia,,Belk	Stanford University	450 Serra Mall	Stanford	California	94305	USA	0	NextSeq 550	other	genomic	OTHER	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN18037884	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10156576	NONE	VeroE6-Cas9 v2	EMCV	SARS-CoV-2 RNA interactome
GPL29759	Expanded Interactome EMCV 2	GSM5102447	Public on Feb 24 2021	Feb 23 2021	Feb 24 2021	SRA	1	VeroE6 cells	Chlorocebus sabaeus	sgrna pool: SARS-CoV-2 RNA interactome	cell line: VeroE6-Cas9 v2	infection: EMCV	Each culture was treated with the virus indicated in the Characteristics "infection" field above to select for resistance or sensitization sgRNAs.	VeroE6 cells expressing Cas9v2 and their respective sgRNA pool were maintained in T150 flasks in 5% FBS.	genomic DNA	gDNA was extracted from each sample using standard commercial kits (Zymo).	Lentivirally-integrated sgRNAs were PCR amplified from each gDNA sample and sequencing adapters and indices were added.	Targeted (amplicon) sequencing	60711	CRISPR sgRNAs from gDNA	exp_counts_table.tsv	exp_emcv_2	Adapter trimming was performed using fastp	Reads were mapped to the relevant sgRNA library using hisat2 and a custom genome (fasta) file for each sgRNA library.	BAM files were converted to counts tables using R package `Rsamtools`	Counts were depth normalized and then z-scored using negative controls	Genome_build: Designed sgRNA sequences were used to create a custom fasta file used for alignments.	Supplementary_files_format_and_content: Counts table for each sgRNA	GPL29759	Julia,,Belk	Stanford University	450 Serra Mall	Stanford	California	94305	USA	0	NextSeq 550	other	genomic	OTHER	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN18037883	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10156577	NONE	VeroE6-Cas9 v2	EMCV	SARS-CoV-2 RNA interactome
GPL29759	Expanded Interactome IAV 1	GSM5102448	Public on Feb 24 2021	Feb 23 2021	Feb 24 2021	SRA	1	VeroE6 cells	Chlorocebus sabaeus	sgrna pool: SARS-CoV-2 RNA interactome	cell line: VeroE6-Cas9 v2	infection: IAV-WSN	Each culture was treated with the virus indicated in the Characteristics "infection" field above to select for resistance or sensitization sgRNAs.	VeroE6 cells expressing Cas9v2 and their respective sgRNA pool were maintained in T150 flasks in 5% FBS.	genomic DNA	gDNA was extracted from each sample using standard commercial kits (Zymo).	Lentivirally-integrated sgRNAs were PCR amplified from each gDNA sample and sequencing adapters and indices were added.	Targeted (amplicon) sequencing	60711	CRISPR sgRNAs from gDNA	exp_counts_table.tsv	exp_iav_1	Adapter trimming was performed using fastp	Reads were mapped to the relevant sgRNA library using hisat2 and a custom genome (fasta) file for each sgRNA library.	BAM files were converted to counts tables using R package `Rsamtools`	Counts were depth normalized and then z-scored using negative controls	Genome_build: Designed sgRNA sequences were used to create a custom fasta file used for alignments.	Supplementary_files_format_and_content: Counts table for each sgRNA	GPL29759	Julia,,Belk	Stanford University	450 Serra Mall	Stanford	California	94305	USA	0	NextSeq 550	other	genomic	OTHER	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN18037882	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10156578	NONE	VeroE6-Cas9 v2	IAV-WSN	SARS-CoV-2 RNA interactome
GPL29759	Mito screen Mock 1	GSM5102449	Public on Feb 24 2021	Feb 23 2021	Feb 24 2021	SRA	1	VeroE6 cells	Chlorocebus sabaeus	sgrna pool: Mito proteins	cell line: VeroE6-Cas9 v2	infection: none	Each culture was treated with the virus indicated in the Characteristics "infection" field above to select for resistance or sensitization sgRNAs.	VeroE6 cells expressing Cas9v2 and their respective sgRNA pool were maintained in T150 flasks in 5% FBS.	genomic DNA	gDNA was extracted from each sample using standard commercial kits (Zymo).	Lentivirally-integrated sgRNAs were PCR amplified from each gDNA sample and sequencing adapters and indices were added.	Targeted (amplicon) sequencing	60711	CRISPR sgRNAs from gDNA	mito_counts_table.tsv	mito_mock_1	Adapter trimming was performed using fastp	Reads were mapped to the relevant sgRNA library using hisat2 and a custom genome (fasta) file for each sgRNA library.	BAM files were converted to counts tables using R package `Rsamtools`	Counts were depth normalized and then z-scored using negative controls	Genome_build: Designed sgRNA sequences were used to create a custom fasta file used for alignments.	Supplementary_files_format_and_content: Counts table for each sgRNA	GPL29759	Julia,,Belk	Stanford University	450 Serra Mall	Stanford	California	94305	USA	0	NextSeq 550	other	genomic	OTHER	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN18037881	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10156579	NONE	VeroE6-Cas9 v2	none	Mito proteins
GPL29759	Mito screen Mock 2	GSM5102450	Public on Feb 24 2021	Feb 23 2021	Feb 24 2021	SRA	1	VeroE6 cells	Chlorocebus sabaeus	sgrna pool: Mito proteins	cell line: VeroE6-Cas9 v2	infection: none	Each culture was treated with the virus indicated in the Characteristics "infection" field above to select for resistance or sensitization sgRNAs.	VeroE6 cells expressing Cas9v2 and their respective sgRNA pool were maintained in T150 flasks in 5% FBS.	genomic DNA	gDNA was extracted from each sample using standard commercial kits (Zymo).	Lentivirally-integrated sgRNAs were PCR amplified from each gDNA sample and sequencing adapters and indices were added.	Targeted (amplicon) sequencing	60711	CRISPR sgRNAs from gDNA	mito_counts_table.tsv	mito_mock_2	Adapter trimming was performed using fastp	Reads were mapped to the relevant sgRNA library using hisat2 and a custom genome (fasta) file for each sgRNA library.	BAM files were converted to counts tables using R package `Rsamtools`	Counts were depth normalized and then z-scored using negative controls	Genome_build: Designed sgRNA sequences were used to create a custom fasta file used for alignments.	Supplementary_files_format_and_content: Counts table for each sgRNA	GPL29759	Julia,,Belk	Stanford University	450 Serra Mall	Stanford	California	94305	USA	0	NextSeq 550	other	genomic	OTHER	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN18037906	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10156580	NONE	VeroE6-Cas9 v2	none	Mito proteins
GPL29759	Mito screen rcVSV 2	GSM5102452	Public on Feb 24 2021	Feb 23 2021	Feb 24 2021	SRA	1	VeroE6 cells	Chlorocebus sabaeus	sgrna pool: Mito proteins	cell line: VeroE6-Cas9 v2	infection: rcVSV-SARS-2-S	Each culture was treated with the virus indicated in the Characteristics "infection" field above to select for resistance or sensitization sgRNAs.	VeroE6 cells expressing Cas9v2 and their respective sgRNA pool were maintained in T150 flasks in 5% FBS.	genomic DNA	gDNA was extracted from each sample using standard commercial kits (Zymo).	Lentivirally-integrated sgRNAs were PCR amplified from each gDNA sample and sequencing adapters and indices were added.	Targeted (amplicon) sequencing	60711	CRISPR sgRNAs from gDNA	mito_counts_table.tsv	mito_rcVSV_2	Adapter trimming was performed using fastp	Reads were mapped to the relevant sgRNA library using hisat2 and a custom genome (fasta) file for each sgRNA library.	BAM files were converted to counts tables using R package `Rsamtools`	Counts were depth normalized and then z-scored using negative controls	Genome_build: Designed sgRNA sequences were used to create a custom fasta file used for alignments.	Supplementary_files_format_and_content: Counts table for each sgRNA	GPL29759	Julia,,Belk	Stanford University	450 Serra Mall	Stanford	California	94305	USA	0	NextSeq 550	other	genomic	OTHER	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN18037904	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10156582	NONE	VeroE6-Cas9 v2	rcVSV-SARS-2-S	Mito proteins
GPL29759	Mito screen HKU5 1	GSM5102453	Public on Feb 24 2021	Feb 23 2021	Feb 24 2021	SRA	1	VeroE6 cells	Chlorocebus sabaeus	sgrna pool: Mito proteins	cell line: VeroE6-Cas9 v2	infection: HKU5-SARS1	Each culture was treated with the virus indicated in the Characteristics "infection" field above to select for resistance or sensitization sgRNAs.	VeroE6 cells expressing Cas9v2 and their respective sgRNA pool were maintained in T150 flasks in 5% FBS.	genomic DNA	gDNA was extracted from each sample using standard commercial kits (Zymo).	Lentivirally-integrated sgRNAs were PCR amplified from each gDNA sample and sequencing adapters and indices were added.	Targeted (amplicon) sequencing	60711	CRISPR sgRNAs from gDNA	mito_counts_table.tsv	mito_hku5_1	Adapter trimming was performed using fastp	Reads were mapped to the relevant sgRNA library using hisat2 and a custom genome (fasta) file for each sgRNA library.	BAM files were converted to counts tables using R package `Rsamtools`	Counts were depth normalized and then z-scored using negative controls	Genome_build: Designed sgRNA sequences were used to create a custom fasta file used for alignments.	Supplementary_files_format_and_content: Counts table for each sgRNA	GPL29759	Julia,,Belk	Stanford University	450 Serra Mall	Stanford	California	94305	USA	0	NextSeq 550	other	genomic	OTHER	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN18037901	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10156583	NONE	VeroE6-Cas9 v2	HKU5-SARS1	Mito proteins
GPL29759	Mito screen HKU5 2	GSM5102454	Public on Feb 24 2021	Feb 23 2021	Feb 24 2021	SRA	1	VeroE6 cells	Chlorocebus sabaeus	sgrna pool: Mito proteins	cell line: VeroE6-Cas9 v2	infection: HKU5-SARS1	Each culture was treated with the virus indicated in the Characteristics "infection" field above to select for resistance or sensitization sgRNAs.	VeroE6 cells expressing Cas9v2 and their respective sgRNA pool were maintained in T150 flasks in 5% FBS.	genomic DNA	gDNA was extracted from each sample using standard commercial kits (Zymo).	Lentivirally-integrated sgRNAs were PCR amplified from each gDNA sample and sequencing adapters and indices were added.	Targeted (amplicon) sequencing	60711	CRISPR sgRNAs from gDNA	mito_counts_table.tsv	mito_hku5_2	Adapter trimming was performed using fastp	Reads were mapped to the relevant sgRNA library using hisat2 and a custom genome (fasta) file for each sgRNA library.	BAM files were converted to counts tables using R package `Rsamtools`	Counts were depth normalized and then z-scored using negative controls	Genome_build: Designed sgRNA sequences were used to create a custom fasta file used for alignments.	Supplementary_files_format_and_content: Counts table for each sgRNA	GPL29759	Julia,,Belk	Stanford University	450 Serra Mall	Stanford	California	94305	USA	0	NextSeq 550	other	genomic	OTHER	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN18037900	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10156584	NONE	VeroE6-Cas9 v2	HKU5-SARS1	Mito proteins
GPL29759	Mito screen SARS2 1	GSM5102455	Public on Feb 24 2021	Feb 23 2021	Feb 24 2021	SRA	1	VeroE6 cells	Chlorocebus sabaeus	sgrna pool: Mito proteins	cell line: VeroE6-Cas9 v2	infection: SARS-CoV-2	Each culture was treated with the virus indicated in the Characteristics "infection" field above to select for resistance or sensitization sgRNAs.	VeroE6 cells expressing Cas9v2 and their respective sgRNA pool were maintained in T150 flasks in 5% FBS.	genomic DNA	gDNA was extracted from each sample using standard commercial kits (Zymo).	Lentivirally-integrated sgRNAs were PCR amplified from each gDNA sample and sequencing adapters and indices were added.	Targeted (amplicon) sequencing	60711	CRISPR sgRNAs from gDNA	mito_counts_table.tsv	mito_sars2_1	Adapter trimming was performed using fastp	Reads were mapped to the relevant sgRNA library using hisat2 and a custom genome (fasta) file for each sgRNA library.	BAM files were converted to counts tables using R package `Rsamtools`	Counts were depth normalized and then z-scored using negative controls	Genome_build: Designed sgRNA sequences were used to create a custom fasta file used for alignments.	Supplementary_files_format_and_content: Counts table for each sgRNA	GPL29759	Julia,,Belk	Stanford University	450 Serra Mall	Stanford	California	94305	USA	0	NextSeq 550	other	genomic	OTHER	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN18037899	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10156585	NONE	VeroE6-Cas9 v2	SARS-CoV-2	Mito proteins
GPL29759	Mito screen SARS2 2	GSM5102456	Public on Feb 24 2021	Feb 23 2021	Feb 24 2021	SRA	1	VeroE6 cells	Chlorocebus sabaeus	sgrna pool: Mito proteins	cell line: VeroE6-Cas9 v2	infection: SARS-CoV-2	Each culture was treated with the virus indicated in the Characteristics "infection" field above to select for resistance or sensitization sgRNAs.	VeroE6 cells expressing Cas9v2 and their respective sgRNA pool were maintained in T150 flasks in 5% FBS.	genomic DNA	gDNA was extracted from each sample using standard commercial kits (Zymo).	Lentivirally-integrated sgRNAs were PCR amplified from each gDNA sample and sequencing adapters and indices were added.	Targeted (amplicon) sequencing	60711	CRISPR sgRNAs from gDNA	mito_counts_table.tsv	mito_sars2_2	Adapter trimming was performed using fastp	Reads were mapped to the relevant sgRNA library using hisat2 and a custom genome (fasta) file for each sgRNA library.	BAM files were converted to counts tables using R package `Rsamtools`	Counts were depth normalized and then z-scored using negative controls	Genome_build: Designed sgRNA sequences were used to create a custom fasta file used for alignments.	Supplementary_files_format_and_content: Counts table for each sgRNA	GPL29759	Julia,,Belk	Stanford University	450 Serra Mall	Stanford	California	94305	USA	0	NextSeq 550	other	genomic	OTHER	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN18037898	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10156586	NONE	VeroE6-Cas9 v2	SARS-CoV-2	Mito proteins
GPL29759	Mito screen MERS 1	GSM5102457	Public on Feb 24 2021	Feb 23 2021	Feb 24 2021	SRA	1	VeroE6 cells	Chlorocebus sabaeus	sgrna pool: Mito proteins	cell line: VeroE6-Cas9 v2	infection: MERS WT	Each culture was treated with the virus indicated in the Characteristics "infection" field above to select for resistance or sensitization sgRNAs.	VeroE6 cells expressing Cas9v2 and their respective sgRNA pool were maintained in T150 flasks in 5% FBS.	genomic DNA	gDNA was extracted from each sample using standard commercial kits (Zymo).	Lentivirally-integrated sgRNAs were PCR amplified from each gDNA sample and sequencing adapters and indices were added.	Targeted (amplicon) sequencing	60711	CRISPR sgRNAs from gDNA	mito_counts_table.tsv	mito_mers_1	Adapter trimming was performed using fastp	Reads were mapped to the relevant sgRNA library using hisat2 and a custom genome (fasta) file for each sgRNA library.	BAM files were converted to counts tables using R package `Rsamtools`	Counts were depth normalized and then z-scored using negative controls	Genome_build: Designed sgRNA sequences were used to create a custom fasta file used for alignments.	Supplementary_files_format_and_content: Counts table for each sgRNA	GPL29759	Julia,,Belk	Stanford University	450 Serra Mall	Stanford	California	94305	USA	0	NextSeq 550	other	genomic	OTHER	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN18037897	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10156587	NONE	VeroE6-Cas9 v2	MERS WT	Mito proteins
GPL29759	Mito screen T1015N 1	GSM5102459	Public on Feb 24 2021	Feb 23 2021	Feb 24 2021	SRA	1	VeroE6 cells	Chlorocebus sabaeus	sgrna pool: Mito proteins	cell line: VeroE6-Cas9 v2	infection: MERS T1015N	Each culture was treated with the virus indicated in the Characteristics "infection" field above to select for resistance or sensitization sgRNAs.	VeroE6 cells expressing Cas9v2 and their respective sgRNA pool were maintained in T150 flasks in 5% FBS.	genomic DNA	gDNA was extracted from each sample using standard commercial kits (Zymo).	Lentivirally-integrated sgRNAs were PCR amplified from each gDNA sample and sequencing adapters and indices were added.	Targeted (amplicon) sequencing	60711	CRISPR sgRNAs from gDNA	mito_counts_table.tsv	mito_t1015n_1	Adapter trimming was performed using fastp	Reads were mapped to the relevant sgRNA library using hisat2 and a custom genome (fasta) file for each sgRNA library.	BAM files were converted to counts tables using R package `Rsamtools`	Counts were depth normalized and then z-scored using negative controls	Genome_build: Designed sgRNA sequences were used to create a custom fasta file used for alignments.	Supplementary_files_format_and_content: Counts table for each sgRNA	GPL29759	Julia,,Belk	Stanford University	450 Serra Mall	Stanford	California	94305	USA	0	NextSeq 550	other	genomic	OTHER	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN18037895	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10156589	NONE	VeroE6-Cas9 v2	MERS T1015N	Mito proteins
GPL29759	Mito screen EMCV 1	GSM5102461	Public on Feb 24 2021	Feb 23 2021	Feb 24 2021	SRA	1	VeroE6 cells	Chlorocebus sabaeus	sgrna pool: Mito proteins	cell line: VeroE6-Cas9 v2	infection: EMCV	Each culture was treated with the virus indicated in the Characteristics "infection" field above to select for resistance or sensitization sgRNAs.	VeroE6 cells expressing Cas9v2 and their respective sgRNA pool were maintained in T150 flasks in 5% FBS.	genomic DNA	gDNA was extracted from each sample using standard commercial kits (Zymo).	Lentivirally-integrated sgRNAs were PCR amplified from each gDNA sample and sequencing adapters and indices were added.	Targeted (amplicon) sequencing	60711	CRISPR sgRNAs from gDNA	mito_counts_table.tsv	mito_emcv_1	Adapter trimming was performed using fastp	Reads were mapped to the relevant sgRNA library using hisat2 and a custom genome (fasta) file for each sgRNA library.	BAM files were converted to counts tables using R package `Rsamtools`	Counts were depth normalized and then z-scored using negative controls	Genome_build: Designed sgRNA sequences were used to create a custom fasta file used for alignments.	Supplementary_files_format_and_content: Counts table for each sgRNA	GPL29759	Julia,,Belk	Stanford University	450 Serra Mall	Stanford	California	94305	USA	0	NextSeq 550	other	genomic	OTHER	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN18037909	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10156591	NONE	VeroE6-Cas9 v2	EMCV	Mito proteins
GPL29759	Mito screen EMCV 2	GSM5102462	Public on Feb 24 2021	Feb 23 2021	Feb 24 2021	SRA	1	VeroE6 cells	Chlorocebus sabaeus	sgrna pool: Mito proteins	cell line: VeroE6-Cas9 v2	infection: EMCV	Each culture was treated with the virus indicated in the Characteristics "infection" field above to select for resistance or sensitization sgRNAs.	VeroE6 cells expressing Cas9v2 and their respective sgRNA pool were maintained in T150 flasks in 5% FBS.	genomic DNA	gDNA was extracted from each sample using standard commercial kits (Zymo).	Lentivirally-integrated sgRNAs were PCR amplified from each gDNA sample and sequencing adapters and indices were added.	Targeted (amplicon) sequencing	60711	CRISPR sgRNAs from gDNA	mito_counts_table.tsv	mito_emcv_2	Adapter trimming was performed using fastp	Reads were mapped to the relevant sgRNA library using hisat2 and a custom genome (fasta) file for each sgRNA library.	BAM files were converted to counts tables using R package `Rsamtools`	Counts were depth normalized and then z-scored using negative controls	Genome_build: Designed sgRNA sequences were used to create a custom fasta file used for alignments.	Supplementary_files_format_and_content: Counts table for each sgRNA	GPL29759	Julia,,Belk	Stanford University	450 Serra Mall	Stanford	California	94305	USA	0	NextSeq 550	other	genomic	OTHER	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN18037908	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10156592	NONE	VeroE6-Cas9 v2	EMCV	Mito proteins
GPL29759	Mito screen IAV 1	GSM5102463	Public on Feb 24 2021	Feb 23 2021	Feb 24 2021	SRA	1	VeroE6 cells	Chlorocebus sabaeus	sgrna pool: Mito proteins	cell line: VeroE6-Cas9 v2	infection: IAV-WSN	Each culture was treated with the virus indicated in the Characteristics "infection" field above to select for resistance or sensitization sgRNAs.	VeroE6 cells expressing Cas9v2 and their respective sgRNA pool were maintained in T150 flasks in 5% FBS.	genomic DNA	gDNA was extracted from each sample using standard commercial kits (Zymo).	Lentivirally-integrated sgRNAs were PCR amplified from each gDNA sample and sequencing adapters and indices were added.	Targeted (amplicon) sequencing	60711	CRISPR sgRNAs from gDNA	mito_counts_table.tsv	mito_iav_1	Adapter trimming was performed using fastp	Reads were mapped to the relevant sgRNA library using hisat2 and a custom genome (fasta) file for each sgRNA library.	BAM files were converted to counts tables using R package `Rsamtools`	Counts were depth normalized and then z-scored using negative controls	Genome_build: Designed sgRNA sequences were used to create a custom fasta file used for alignments.	Supplementary_files_format_and_content: Counts table for each sgRNA	GPL29759	Julia,,Belk	Stanford University	450 Serra Mall	Stanford	California	94305	USA	0	NextSeq 550	other	genomic	OTHER	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN18037903	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10156593	NONE	VeroE6-Cas9 v2	IAV-WSN	Mito proteins
